CompletedNot Applicable

Effect of a Preoperative Video Education Program on ICU Delirium After CABG (VIDEO-CABG Trial)

Jordan220 participantsStarted 2026-01-03

Plain-language summary

The goal of this clinical trial is to evaluate the effect of a preoperative video-based educational program on postoperative outcomes in adult patients undergoing coronary artery bypass graft (CABG) surgery. The main questions it aims to answer are: Does the video-based educational program reduce the incidence of ICU delirium after CABG surgery? Does the program improve recovery outcomes, including length of ICU stay, hospital stay, and time to early ambulation? Researchers will compare patients receiving the video-based educational program (intervention group) with those receiving standard care (control group) to determine whether the intervention improves postoperative outcomes. Participants will: Be randomly assigned to either the intervention or control group Receive either a structured preoperative video-based education program or standard verbal education Be assessed for ICU delirium using the CAM-ICU tool during ICU stay Have their length of ICU stay and hospital stay recorded from medical records Be monitored for early ambulation within the first 72 hours after surgery

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Adult patients aged 18 years or older
. Scheduled for first-time, elective Coronary Artery Bypass Graft (CABG) surgery
. Able to read and understand Arabic
. Admitted preoperatively with sufficient time to receive the intervention (at least 24 hours before surgery)

Exclusion criteria

. Undergoing emergency or urgent CABG surgery
. Previous CABG (redo surgery)
. Cognitive impairment (e.g., diagnosed dementia, severe cognitive deficits, or Alzheimer's disease)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Incidence of ICU Delirium

Timeframe: Assessed twice daily (6 AM and 6 PM) during ICU stay, up to discharge from ICU. for three months

Trial details

NCT IDNCT07570420

SponsorUniversity of Jordan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-10

View on ClinicalTrials.gov More CABG trials